Provexis Plc

0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Provexis Plc LSE:PXS London Ordinary Share GB00B0923P27 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 0.60 498,828 09:50:33
Bid Price Offer Price High Price Low Price Open Price
0.60 0.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Processors Div'd 0.43 -0.24 - - 13.31
Last Trade Time Trade Type Trade Size Trade Price Currency
09:50:16 O 498,828 0.64 GBX

Provexis (PXS) Latest News

Provexis (PXS) Discussions and Chat

Provexis (PXS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-06-07 15:36:570.561,196,5426,700.64O
2023-06-07 14:13:290.61500,0003,050.00O

Provexis (PXS) Top Chat Posts

Top Posts
Posted at 31/5/2023 14:03 by oldham45
Healthspan. Circulease has been my main supplier. I used to get half price offers on this product and stocked up, but seems to have stopped.
Posted at 24/5/2023 16:28 by winner31
The present revenue has little relevance to pxs going forward , and if the board have prioritised the By-health contract for these others then maybe we can get the revenue growing a lot quicker than from the likes of H&B , to be honest h&b have not pushed this product once in the 5 years since the contract started , I go into H&b quite a lot and ff+ has never been in your face when you walk in even in the early days , so good riddance if the contract is over , we have much bigger fish to fry imho.
Posted at 24/5/2023 07:18 by gix er
BB, I agree that not being able to supply customers is bad news but there is no evidence that would suggest that the above products being out of stock is anything to do with the lack of FF being supplied by Provexis or DSM.

Yes there could have been a delay due to the company signing contracts with Healthspan and Simply Supplements but there could also be various other reasons. Both Healthspan and Simply say there products are manufactured in the UK (possibly the same manufacturer)and there could be an issue with them. We don't even know if these companies are direct customers of Provexis and may be waiting on DSM to supply the premix. Not the first time products have been out of stock for a long time when DSM were in charge. Swanson FF (now gone) springs to mind.

Holland and Barrett is a different situation and we know Fruitflow Plus is a DSM market ready solutions product (could be a premix but doubt it) so if stock is low then you could blame pxs/dsm but, and I hope I am wrong, I think the Holland and Barrett relationship has come to an end.

So Yes it could have been an issue with the hand over or long lead times with DSM supplying premixes/market ready solutions but it could easily be something else altogether.

"balls up" possibly, but not necessarily ours or DSM's.

2 new products came to market very recently and it looks like PXS could have supplied the FF for them.

Posted at 23/5/2023 22:11 by bareknee
Nearly the end of May, so not far off being five months into being responsible for supplying Fruitflow to customers and a quick check shows :-

Simply Supplements ( Blood Pressure Formula ) out of stock ( and have been a while )
Holland Barrett out of stock of FF+ ( not sure how long for )
Healthspan out of stock ( Circulease ) on their website, expected to be back in stock in August.
Provexis have, I presume, stock ( doesn't say otherwise on the website )

Circulease from Healthspan is in stock on Amazon though, as is FF+ from PXS via Amazon.

Granted, some teething problems on taking over the distribution were to be expected, but it is currently looking like a balls up, not necessarily by Ford, he could have been let down by DSM, but not being able to supply regular customers, however small, isn't a great start.

Obviously, if you wanted to be 100% positive about the situation you could argue that our FF stock has been low because ByHealth have got first dabs on it, which may even be correct, but it's not a good look.


Posted at 09/5/2023 18:37 by gix er
The agreement with DSM was due to end at the end of last year and a new agreement, starting on 1-1-2023 was negotiated.

DSM should still be taking the same amount of Fruitflow through the Premix and Market-Ready Solutions supply agreement and more if the new partnership with DSM relating to the gut microbiome patent takes off.
Only difference is, PXS will now be selling Fruitflow to DSM.
Profit should be materially ahead of the net share of the profit that would have accrued to Provexis with like for like sales and margins under the 2010 Alliance Agreement.

Time will tell but it looks like I.F got us a good deal.

Posted at 09/5/2023 13:33 by nestoframpers
Jam tomorrow , oh wait a minute the pot is empty.

I.F is not CEO material PXS should not be here now. Why has DSM given up their contract?

Posted at 05/4/2023 09:28 by redprince
I do hope that now PXS have control over sales that IF will have complete control over granting exclusivity to a major player in a given territory.This was the reason why Unilever or CC walked away all those years ago - a fact confirmed to me by a former director.
It is almost certainly the same reason why MM dropped the shot format of FF at the last moment - again i know this was a major issue from talking to the lady who was organising the marketing campaign for the shot format.
I wonder if DSM's large corporate structure with layers of decision makers required to
get a sign off on a particular deal and the changing of faces over the years have all contributed to failing to sign a major player after all these years?
At least from now we should be able to get much closer to the answers as we are not dealing with DSM's confidential agreement.

Posted at 04/4/2023 15:56 by winner31
Or could it be that the €550k of ff pxs have committed to buy is the longest dated and the remainder that DSM hold has a shorter shelf life ! Hence the need to test that batch .
Posted at 17/5/2020 12:21 by winner31
Rich i have always thought that DSM have their own agenda when it comes to ff , of course it would be in their interest to not allow the pxs share price to get ahead of itself with regard to market cap ,we all know what happened 10 years or so ago , does anyone else think it’s strange that some years DSM throw £20 or 30k for marketing and so boosting the revenue of pxs and the the next year nothing , so flattening out any spikes in revenue and so the share price , all looks to me like they will make a bid at some stage but only what they want to pay and no more ,may be 3p which in my opinion way under values the potential of the technology .
Posted at 19/10/2019 15:49 by winner31
Notable News Buzz: Provexis Plc, (LON: PXS)

October 18, 2019 No Comments LON: PXSProvexis Plc
On Thursday the Provexis Plc, LON: PXS), the Trending-Graph. Every buying and selling session display one-of-a-kind measures and patterns about PXS stock.Now we observed the Many factors that seen on close of the Previous session. Toward the day’s end, it’s only a stock’s show that issues.

Summary Of The Provexis Plc In Stock Exchange LON:

The PXS share price closed at 0.38 with the change of 0.03 during the period of last trading session. Trading volume can help an investor to identify the momentum in a stock and confirm a trend. If trading volume raised, prices generally move in a similar direction. That is, if security is proceeding higher in an uptrend, the volume of the protection should also increase and vice versa. The Company’s current volume remained at 3424534.00. It will be even better to share yesterday’s volume of the Company, i.e., 1237316.00.

Market Capitalization of Provexis Plc :

Market Capitalization is the accurate measure of a company’s value. There’s a common misconception that a company’s each-share stock price holds as much importance as its market capitalization when it comes to picking stocks to buy. This fallacy occurs especially often in the case of new investors. The market capitalization of the Company recorded at PXS.

Buy/Sell/Hold Analysis of PXS:

Buy Signals: An event or condition that alerts a person to place a purchase order for an investment. Buy signals can be either observed by analyzing chart patterns or calculated by trading systems.

Hold Signals: An analyst’s recommendation to neither purchase nor sell a security. A company or organization with a hold recommendation mostly is required to perform with the market or a similar pace as comparable companies.

Provexis share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230608 13:03:21